China Launches First Policy for Marine Biopharma, Aims for $19B by 2030

China extols potential of AI in guideline on marine biopharmaceuticals

China is stepping up efforts to explore the potential of medically important marine plants and animals, a field already valued in the billions of US dollars, as it looks to bolster its pharmaceutical industry. The country’s first guideline for the marine biopharmaceutical industry, released by the Ministry of Natural Resources on Thursday, encouraged research institutions and drug makers to leverage artificial intelligence (AI) technologies to s…

China Launches First Policy for Marine Biopharma, Aims for $19B by 2030

China has introduced its first comprehensive national policy for the marine biopharmaceutical industry, aiming to foster the development of multiple innovative marine drugs and reach an industry value exceeding CNY130 billion (approximately USD19.2 billion) by 2030. The policy, announced by the Ministry of Natural Resources along with eight other government agencies, outlines 15 specific initiatives across five key sectors: enhancing resource su…